IDYA

29.26

5.67% 1.57

Handel nachbörslich: 30.28 1.02 +3.49%

Ideaya Biosciences Inc (IDYA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$27.69

Offen:

$27.31

24-Stunden-Volumen:

3.59M

Relative Volume:

3.00

Marktkapitalisierung:

$2.56B

Einnahmen:

$23.38M

Nettoeinkommen (Verlust:

$-155.22M

KGV:

-13.36

EPS:

-2.19

Netto-Cashflow:

$-134.36M

1W Leistung:

+11.51%

1M Leistung:

+19.72%

6M Leistung:

+71.31%

1J Leistung:

-4.66%

1-Tages-Spanne:

$26.89

$31.07

1-Wochen-Bereich:

$26.20

$31.07

52-Wochen-Spanne:

$13.45

$32.67

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Firmenname

Ideaya Biosciences Inc

Sektor

Healthcare (1134)

Branche

Biotechnology (636)

Telefon

650-443-6209

Adresse

5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA

Mitarbeiter

131

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

IDYA's Discussions on Twitter

Vergleichen Sie IDYA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IDYA Ideaya Biosciences Inc	29.26	2.43B	23.38M	-155.22M	-134.36M	-2.19
VRTX Vertex Pharmaceuticals Inc	416.81	104.76B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.67	63.06B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	578.05	60.32B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	843.66	51.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	165.76	34.49B	398.11M	-1.03B	-868.57M	-5.7032

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-18	Eingeleitet	Guggenheim	Buy
2025-09-04	Eingeleitet	Barclays	Overweight
2025-09-04	Eingeleitet	Citizens JMP	Mkt Outperform
2025-07-22	Eingeleitet	TD Cowen	Buy
2025-07-10	Fortgesetzt	Goldman	Neutral
2025-06-26	Eingeleitet	Wells Fargo	Overweight
2024-11-18	Eingeleitet	Stephens	Overweight
2024-11-05	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-10-24	Eingeleitet	UBS	Buy
2024-10-15	Eingeleitet	Cantor Fitzgerald	Overweight
2024-07-08	Eingeleitet	Mizuho	Outperform
2024-03-08	Eingeleitet	BTIG Research	Buy
2023-08-08	Eingeleitet	SVB Securities	Outperform
2023-05-24	Eingeleitet	Goldman	Buy
2023-04-24	Hochstufung	Stifel	Hold → Buy
2023-03-23	Eingeleitet	Berenberg	Buy
2023-02-28	Eingeleitet	RBC Capital Mkts	Outperform
2022-12-28	Eingeleitet	CapitalOne	Overweight
2022-10-27	Eingeleitet	Citigroup	Buy
2022-08-15	Herabstufung	Stifel	Buy → Hold
2022-07-18	Fortgesetzt	Oppenheimer	Outperform
2022-03-10	Hochstufung	Stifel	Hold → Buy
2021-09-23	Eingeleitet	Stifel	Hold
2021-06-04	Fortgesetzt	Robert W. Baird	Outperform
2021-03-11	Eingeleitet	Guggenheim	Buy
2020-10-07	Eingeleitet	Wedbush	Outperform
2020-09-01	Eingeleitet	Northland Capital	Outperform
2020-07-13	Hochstufung	JP Morgan	Neutral → Overweight
2020-06-17	Bestätigt	H.C. Wainwright	Buy
2020-04-06	Eingeleitet	H.C. Wainwright	Buy
2020-03-13	Eingeleitet	ROTH Capital	Buy
2019-10-17	Eingeleitet	Oppenheimer	Outperform
2019-09-10	Eingeleitet	Robert W. Baird	Outperform
2019-06-17	Eingeleitet	Citigroup	Buy
2019-06-17	Eingeleitet	JP Morgan	Neutral
2019-06-17	Eingeleitet	Jefferies	Buy

Alle ansehen

Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten

03:11 AM

Will IDEAYA Biosciences Inc. stock deliver shareholder valueJuly 2025 Outlook & Capital Efficiency Focused Strategies - Trung tâm Dự báo KTTV quốc gia

03:11 AM

11:37 AM

Is IDEAYA Biosciences Inc. stock in correction or buying zoneQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com

11:37 AM

04:26 AM

Has IDEAYA Biosciences Inc. formed a bullish divergenceJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com

04:26 AM

02:17 AM

Is IDEAYA Biosciences Inc. forming a reversal patternQuarterly Earnings Report & Weekly Market Pulse Updates - newser.com

02:17 AM

01:38 AM

Will IDEAYA Biosciences Inc. stock split again soonGDP Growth & Stock Portfolio Risk Control - newser.com

01:38 AM

Oct 15, 2025

Is IDEAYA Biosciences Inc. showing signs of accumulationJobs Report & Weekly Consistent Profit Watchlists - newser.com

Oct 15, 2025

Is IDEAYA Biosciences Inc. still worth holding after the dipPortfolio Update Report & Weekly Setup with ROI Potential - newser.com

Oct 15, 2025

How IDEAYA Biosciences Inc. (30J) stock compares with market leaders2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com

Oct 15, 2025

Oct 14, 2025

Visualizing IDEAYA Biosciences Inc. stock with heatmapsChart Signals & High Win Rate Trade Alerts - newser.com

Oct 14, 2025

Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.

Oct 14, 2025

Oct 13, 2025

Ideaya Biosciences stock rating reiterated at Market Outperform by Citizens - Investing.com Canada

Oct 13, 2025

Oct 12, 2025

IDEAYA Biosciences Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 12, 2025

Oct 11, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Stock Rating Lowered by Wall Street Zen - MarketBeat

Oct 11, 2025

Oct 10, 2025

Can IDEAYA Biosciences Inc. stock maintain growth trajectoryTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025

Oct 09, 2025

What analysts say about IDEAYA Biosciences Inc stockGrowth vs. Value Investing & Boost Wealth With Growth - earlytimes.in

Oct 09, 2025

IDEAYA Biosciences' (IDYA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

J.P. Morgan Remains Bullish on IDEAYA Biosciences (IDYA) - Insider Monkey

Oct 08, 2025

Oct 07, 2025

Ideaya Biosciences stock maintains Market Outperform rating at Citizens - Investing.com

Oct 07, 2025

Oct 06, 2025

IDEAYA Biosciences Inc. stock outlook for YEARTrade Volume Report & Reliable Intraday Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025